Replicate Design [General Sta­tis­tics]

posted by ratnakar1811 – India, 2008-09-02 16:34 (5984 d 15:18 ago) – Posting: # 2303
Views: 7,107

Dear Labes and forum members,

AS per the draft guideline which mentions that, "All treated subjects should be included in the statistical analysis, with the exception of subjects in a crossover trial who do not complete at least one period receiving each of the test and reference products (or who fail to complete the single period in a parallel group trial)." which i guess, means that in a crossover trial if it is a two period study subject should complete both the periods and in case of replicate study subject should complete at least two periods receiving test and reference at least once can be considered.

Comment!

Ratnakar Jadhav

Complete thread:

UA Flag
Activity
 Admin contact
23,363 posts in 4,906 threads, 1,677 registered users;
147 visitors (0 registered, 147 guests [including 10 identified bots]).
Forum time: 06:53 CET (Europe/Vienna)

The combination of some data and an aching desire
for an answer does not ensure that a reasonable answer
can be extracted from a given body of data.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5